NEXENTIS TECHNOLOGIES INC. Increase (Decrease) in Accounts Receivable
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Increase (Decrease) in Accounts Receivable of -$130.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $132.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$193.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $52.00K, a 33.33% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in accounts receivable for fiscal 2025 was -$9.00K, a 125.00% decline from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in accounts receivable for fiscal 2024 was $36.00K.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in accounts receivable for fiscal 2023 was -$85.00K, a 525.70% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. increase (decrease) in accounts receivable for fiscal 2022 was $19.97K, a 19.13% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$130.00K 10-Q · filed 2026-08-13 | |||||||
| 2025-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$61.00K derived: sum of 2 quarters · filed 2026-03-31 | -$61.00K derived: sum of 3 quarters · filed 2026-08-13 | -$9.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$193.00K derived: sum of 2 quarters · filed 2026-08-13 | -$141.00K 10-Q · filed 2025-11-13 | -$152.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $52.00K 10-Q · filed 2026-08-13 | $41.00K derived: sum of 3 quarters · filed 2026-08-13 | $37.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $52.00K 10-Q · filed 2026-05-14 | $41.00K derived: sum of 2 quarters · filed 2026-05-14 | $37.00K derived: sum of 3 quarters · filed 2026-05-14 | $49.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$15.00K derived: sum of 2 quarters · filed 2026-03-31 | -$3.00K derived: sum of 3 quarters · filed 2026-03-31 | $36.00K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $8.00K derived: sum of 2 quarters · filed 2025-11-13 | $47.00K 10-Q · filed 2025-11-13 | $47.18K 10-Q · filed 2024-11-14 | $108.83K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $51.00K 10-Q · filed 2025-08-14 | $50.96K 10-Q · filed 2024-08-14 | $112.83K derived: sum of 3 quarters · filed 2025-08-14 | $49.08K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $39.00K 10-Q · filed 2025-05-15 | $39.07K 10-Q · filed 2024-05-15 | $100.83K derived: sum of 2 quarters · filed 2025-05-15 | $37.08K derived: sum of 3 quarters · filed 2025-05-15 | -$135.69K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $61.83K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.92K derived: sum of 2 quarters · filed 2025-03-31 | -$174.69K derived: sum of 3 quarters · filed 2025-03-31 | -$85.00K 10-K · filed 2025-03-31 | -$85.59K 10-K · filed 2024-04-01 | |||
| 2023-09-30 | -$63.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$236.53K derived: sum of 2 quarters · filed 2024-11-14 | -$146.83K 10-Q · filed 2024-11-14 | -$3.56K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$172.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$83.08K 10-Q · filed 2024-08-14 | $60.19K derived: sum of 3 quarters · filed 2024-08-14 | $78.44K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $89.69K 10-Q · filed 2024-05-15 | $232.96K derived: sum of 2 quarters · filed 2024-05-15 | $251.21K derived: sum of 3 quarters · filed 2024-05-15 | $80.44K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $143.27K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $161.52K derived: sum of 2 quarters · filed 2024-04-01 | -$9.26K derived: sum of 3 quarters · filed 2024-04-01 | $19.97K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $18.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$152.52K derived: sum of 2 quarters · filed 2023-11-14 | -$123.30K 10-Q · filed 2023-11-14 | $12.53K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$170.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$141.55K 10-Q · filed 2023-08-14 | -$5.72K derived: sum of 3 quarters · filed 2023-08-14 | -$23.32K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $29.22K 10-Q · filed 2023-05-15 | $165.05K derived: sum of 2 quarters · filed 2023-05-15 | $147.45K derived: sum of 3 quarters · filed 2023-05-15 | $43.35K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $135.83K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $118.23K derived: sum of 2 quarters · filed 2023-03-27 | $14.13K derived: sum of 3 quarters · filed 2023-03-27 | $24.69K 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | -$17.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$121.70K derived: sum of 2 quarters · filed 2022-11-14 | -$111.14K 10-Q · filed 2022-11-14 | $36.80K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$104.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$93.54K 10-Q · filed 2022-08-15 | $54.40K derived: sum of 3 quarters · filed 2022-08-15 | $54.40K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $10.56K 10-Q · filed 2022-05-16 | $158.50K derived: sum of 2 quarters · filed 2022-05-16 | $158.50K derived: sum of 3 quarters · filed 2022-05-16 | $158.50K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $147.94K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $147.94K derived: sum of 2 quarters · filed 2022-03-31 | $147.94K derived: sum of 3 quarters · filed 2022-03-31 | $83.94K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | -$64.00K 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$64.00K 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2021-08-16 | -$39.49K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$64.00K 10-Q · filed 2021-05-18 | $0.00 derived: sum of 2 quarters · filed 2021-05-18 | -$39.49K derived: sum of 3 quarters · filed 2021-05-18 | -$162.51K derived: sum of 4 quarters · filed 2021-05-18 | ||||
| 2019-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $24.51K derived: sum of 2 quarters · filed 2021-03-29 | -$98.50K derived: sum of 3 quarters · filed 2021-03-29 | -$71.29K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$39.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$162.51K derived: sum of 2 quarters · filed 2020-11-12 | -$135.30K 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | -$123.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$95.81K 10-Q · filed 2020-08-11 | ||||||
| 2019-03-31 | $27.21K 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | -$4.12K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |